Sr. No. | GENERIC NAME | COMPOSITION | ||
1 | TRAMADOL HYDRCHLORIDE & PARACETAMOL TABLETS U.S.P. | EACH FILM COATED TABLET CONTAINS : | ||
PARACETAMOL | I.P. | 325 mg | ||
TRAMADOL HYDROCHLORIDE | I.P. | 50 mg | ||
EXCIPIENTS | q.s. | |||
COLOUR : YELLOW ODIXE OF IRON & TITANIUM DIOXIDE I.P. | ||||
2 | PANTOPRAZOLE & DOMPERIDONE TABLETS | EACH ENTERIC COATED TABLET CONTAINS: | ||
PANTOPRAZOLE SODIUM SESQUIHYDRATE | I.P. | |||
EQ. TO PANTOPRAZOLE | 40 mg | |||
DOMPERIDONE | I.P. | 10 mg | ||
EXCIPIENTS | q.s. | |||
COLOUR : SUNSET YELLOW FCF | ||||
3 | LEVOCETIRIZINE DIHYDROCHLORIDE, PHENYLEPHRINE HYDROCHLORIDE & PARACETAMOL TABLET | EACH UNCOATED TABLET CONTAINS: | ||
LEVOCETIRIZINE DIHYDROCHLORIDE | I.P. | 5 mg | ||
PHENYLEPHRINE HYDROCHLORIDE | I.P. | 5 mg | ||
PARACETAMOL | I.P. | 325 mg | ||
EXCIPIENTS | q.s. | |||
COLOUR : QUINOLINE YELLOW WS & BRILLIANT BLUE FCF | ||||
4 | DICLOFENAC SODIUM & PARACETAMOL TABLETS | EACH UNCOATED TABLET CONTAINS : | ||
DICLOFENAC SODIUM | I.P. | 50 mg | ||
PARACETAMOL | I.P. | 325 mg | ||
EXCIPIENTS | q.s. | |||
COLOUR : SUNSET YELLOW FCF | ||||
5 | RISPERIDONE & TRIHEXYPHENIDYL HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS : | ||
RISPERIDONE | B.P. | 2 mg | ||
TRIHEXYPHENIDYL HYDROCHLORIDE | B.P. | 2 mg | ||
EXCIPIENTS | q.s. | |||
6 | CLONAZEPAM & PROPRANOLOL HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS : | ||
CLONAZEPAM | I.P. | 0.25 mg | ||
PROPRANOLOL HYDROCHLORIDE | I.P. | 10 mg | ||
EXCIPIENTS | q.s. | |||
7 | CLONAZEPAM & PROPRANOLOL HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS : | ||
CLONAZEPAM | I.P. | 0.5 mg | ||
PROPRANOLOL HYDROCHLORIDE | I.P. | 20 mg | ||
EXCIPIENTS | q.s. | |||
8 | CLONAZEPAM & PROPRANOLOL HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS : | ||
CLONAZEPAM | I.P. | 0.5 mg | ||
PROPRANOLOL HYDROCHLORIDE | I.P. | 10 mg | ||
EXCIPIENTS | q.s. | |||
9 | LEVOCETIRIZINE DIHYDROCHLORIDE TABLETS I.P | EACH FILM COATED TABLET CONTAINS: | ||
LEVOCETIRIZINE DIHYDROCHLORIDE | I.P. | 5 mg | ||
EXCIPIENTS | q.s. | |||
COLOUR: TITANIUM DIOXIDE IP | ||||
10 | PYRIDOXINE HYDROCHLORIDE TABLETS IP | EACH UNCOATED TABLET CONTAINS : | ||
PYRIDOXINE HYDROCHLORIDE | I.P. | 50 mg | ||
EXCIPIENTS | q.s. | |||
11 | LORAZEPAM TABLETS I.P. | EACH UNCOATED MOUTH DISSOLVING TABLET CONTAINS: | ||
LORAZEPAM | I.P. | 3.0 mg | ||
EXCIPIENTS | q.s. | |||
12 | CIPROFLOXACIN HYDROCHLORIDE TABLETS IP | EACH FILM COATED TABLET CONTAINS: | ||
CIPROFLOXACIN HYDROCHLORIDE | I.P. | |||
EQ. to CIPROFLOXACIN | 500 mg | |||
EXCIPIENTS | q.s. | |||
COLOUR : TITANIUM DIOXIDE IP | ||||
13 | CIPROFLOXACIN HYDROCHLORIDE TABLETS IP | EACH FILM COATED TABLET CONTAINS: | ||
CIPROFLOXACIN HYDROCHLORIDE | I.P. | |||
EQ. to CIPROFLOXACIN | 250 mg | |||
EXCIPIENTS | q.s. | |||
COLOUR : TITANIUM DIOXIDE IP | ||||
14 | ACECLOFENAC & PARACETAMOL TABLETS | EACH FILM COATED TABLET CONTAINS: | ||
ACECLOFENAC | I.P. | 100 mg | ||
PARACETAMOL | I.P. | 325 mg | ||
EXCIPIENTS | q.s. | |||
COLOUR: TITANIUM DIOXIDE I.P. | ||||
15 | NIMESULIDE & PARACETAMOL TAB | EACH UNCOATED TABLET CONTAINS : | ||
NIMESULIDE | B.P. | 100 mg | ||
PARACETAMOL | I.P. | 325 mg | ||
EXCIPIENTS | q.s. | |||
(NOT FOR CHILDREN BELOW 12 YEARS) | ||||
16 | PARACETAMOL, PHELYEPHRINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE & CAFFEINE | EACH UNCOATED TABLET CONTAINS : | ||
PARACETAMOL | I.P. | 325 mg | ||
PHENYLEPHRINE HYDROCHLORIDE | I.P. | 25 mg | ||
DIPHENHYDRAMINE HYDROCHLORIDE | 5 mg | |||
CAFFEINE | I.P. | 30 mg | ||
EXCEPIENTS | q.s. | |||
COLOUR : SUNSET YELLOW FCF | ||||
17 | PANTOPRAZOLE TABLET I.P. | EACH ENTERIC COATED TABLET CONTAINS: | ||
PANTOPRAZOLE SODIUM SESQUIHYDRATE | I.P. | |||
EQ. TO PANTOPRAZOLE | 40 mg | |||
EXCIPIENTS | q.s. | |||
COLOUR:TITANIUM DIOXIDE I.P. | ||||
18 | MONTELUKAST SODIUM & LEVOCETIRIZINE DIHYDROCHLORIDE TABLET | EACH FILM COATED TABLET CONTAINS: | ||
MONTELUKAST SODIUM | I.P. | |||
Eq. TO MONTELUKAST | 10 mg | |||
LEVOCETIRIZINE DIHYDROCHLORIDE | I.P. | 5 mg | ||
EXCIPIENTS | q.s. | |||
COLOUR: TITANIUM DIOXIDE I.P. | ||||
19 | CETIRIZINE DIHYDROCHLORIDE, PARACETAMOL, PHENYLEPHRINE HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | ||
CETIRIZINE DIHYDROCHLORIDE | I.P. | 5 mg | ||
PARACETAMOL | I.P. | 325 mg | ||
PHENYLEPHRINE HYDROCHLORIDE | I.P. | 10 mg | ||
EXCIPIENTS | q.s. | |||
COLOUR: SUNSET YELLOW FCF | ||||
20 | CETIRIZINE DIHYDROCHLORIDE, PARACETAMOL, PHENYLEPHRINE HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | ||
CETIRIZINE DIHYDROCHLORIDE | I.P. | 5 mg | ||
PARACETAMOL | I.P. | 325 mg | ||
PHENYLEPHRINE HYDROCHLORIDE | I.P. | 5 mg | ||
EXCIPIENTS | q.s. | |||
COLOUR: SUNSET YELLOW FCF | ||||
21 | TERBINAFINE HYDROCHLORIDE TABLET | EACH UNCOATED TABLET CONTAINS : | ||
TERBINAFINE HYDROCHLORIDE | B.P. | |||
E.Q. TO TERBINAFINE | 500 mg | |||
(IN BETACYCLODEXTRIN) | ||||
EXCIPIENTS | q.s. | |||
22 | TERBINAFINE HYDROCHLORIDE TABLET U.S.P | EACH UNCOATED TABLET CONTAINS : | ||
TERBINAFINE HYDROCHLORIDE | B.P. | |||
E.Q. TO TERBINAFINE | 250 mg | |||
(IN BETACYCLODEXTRIN) | ||||
EXCIPIENTS | q.s. | |||
23 | DICLOFENAC POTASSIUM, PARACETAMOL TABLETS | EACH UNCOATED TABLET CONTAINS: | ||
DICLOFENAC POTASSIUM | B.P. | 50 mg | ||
PARACETAMOL | I.P. | 325 mg | ||
EXCIPIENTS | q.s. | |||
COLOUR:ERYTHROSINE | ||||
24 | DICLOFENAC SODIUM, CHLORZOXAZONE & PARACETAMOL TABLETS | EACH UNCOATED TABLET CONTAINS: | ||
DICLOFENAC SODIUM | I.P. | 50 mg | ||
PARACETAMOL | I.P. | 325 mg | ||
CHLORZOXAZONE | U.S.P. | 250 mg | ||
EXCIPIENTS | q.s. | |||
25 | ONDANSETRON ORALLY DISINTEGRATING TABLETS I.P. | EACH UNCOATED ORALLY DISINTEGRATING TABLET CONTAINS: | ||
ONDANSETRON HYDROCHLORIDE | I.P. | |||
E.Q. TO ONDANSETRON | 4 mg | |||
EXCIPIENTS | q.s. | |||
COLOUR: ERYTHROSINE | ||||
26 | ARTEMETHER & LUMEFANTRINE TABLETS | EACH UNCOATED TABLET CONTAINS: | ||
ARTEMETHER | IP | 80 mg | ||
LUMEFANTRINE | BP | 480 mg | ||
EXCIPIENTS | q.s. | |||
COLOUR : TARTRAZINE | ||||
27 | AZITHROMYCIN DIHYDRATE TABLETS I.P. | EACH FILM COATED TABLET CONTAINS: | ||
AZITHROMYCIN DIHYDRATE | I.P. | |||
EQ. TO ANHYDROUS AZITHROMYCIN | 250 mg | |||
EXCIPIENTS | q.s. | |||
COLOUR: TARTRAZINE LAKE | ||||
28 | AZITHROMYCIN DIHYDRATE TABLETS I.P. | EACH FILM COATED TABLET CONTAINS: | ||
AZITHROMYCIN DIHYDRATE | I.P. | |||
EQ. TO ANHYDROUS AZITHROMYCIN | 500 mg | |||
EXCIPIENTS | q.s. | |||
COLOUR: TITANIUM DIOXIDEI.P. | ||||
29 | DEFLAZACORT TABLETS | EACH UNCOATED TABLET CONTAINS: | ||
DEFLAZACORT | 6 mg | |||
EXCIPIENTS | q.s. | |||
30 | FLUVOXAMINE MELEATE SUSTAINED RELEASE TABLETS | EACH UNCOATED SR TABLET CONTAINS: | ||
FLUVOXAMINE MELEATE | B.P. | 100 mg | ||
EXCIPIENTS | q.s. | |||
31 | FLUCONAZOLE TABLETS I.P. | EACH UNCOATED TABLET CONTAINS: | ||
FLUCONAZOLE | I.P. | 150 mg | ||
EXCIPIENTS | q.s. | |||
COLOUR: PONCEAU 4R | ||||
32 | ETIZOLAM TABLETS | EACH FILM COATED TABLET CONTAINS: | ||
ETIZOLAM | I.P. | 0.5 mg | ||
EXCIPIENTS | q.s. | |||
COLOUR: TITANIUM DIOXIDE I.P. | ||||
33 | FLUCONAZOLE TABLETS I.P. | EACH UNCOATED TABLET CONTAINS: | ||
FLUCONAZOLE | I.P. | 200 mg | ||
EXCIPIENTS | q.s. | |||
34 | FLUCONAZOLE TABLETS I.P. | EACH UNCOATED TABLET CONTAINS: | ||
FLUCONAZOLE | I.P. | 300 mg | ||
EXCIPIENTS | q.s. | |||
35 | FLUCONAZOLE TABLETS I.P. | EACH UNCOATED TABLET CONTAINS: | ||
FLUCONAZOLE | I.P. | 400 mg | ||
EXCIPIENTS | q.s. | |||
45 | ETORICOXIB TABLETS | EACH FILM COATED TABLET CONTAINS | ||
ETORICOXIB | I.P. | 90 mg | ||
EXCIPIENTS | q.s. | |||
COLOUR: RED OXIDE OF IRON & TITANIUM DIOXIDE I.P. | ||||
46 | ETODOLAC & PARACETAMOL TABLETS | EACH FILM COATED TABLET CONTAINS | ||
ETODOLAC | I.P. | 400 mg | ||
PARACETAMOL | I.P. | 325 mg | ||
EXCIPIENTS | q.s. | |||
COLOUR SUNSET YELLOW FCF | ||||
47 | ETORICOXIB & THIOCOLCHICOSIDE TABLETS | EACH FILM COATED TABLET CONTAINS | ||
ETORICOXIB | I.P. | 60 mg | ||
THIOCOLCHICOSIDE | I.P. | 4 mg | ||
EXCIPIENTS | q.s. | |||
COLOUR: RED OXIDE OF IRON & TITANIUM DIOXIDE I.P. | ||||
48 | NORTRIPTYLINE TABLETS I.P. | EACH FILM COATED TABLET CONTAINS | ||
NORTRIPTYLINE HYDROCHLORIDE | I.P. | 10 mg | ||
EQ. TO NORTRIPTYLINE | ||||
EXCIPIENTS | q.s. | |||
COLOUR : TITANIUM DIOXIDE IP | ||||
49 | KETOCONAZOLE TABLETS I.P. | EACH UNCOATED TABLET CONTAINS: | ||
KETOCONAZOLE | I.P. | 200 mg | ||
EXCIPIENTS | q.s. | |||
50 | PROPRANOLOL HYDROCHLORIDE (ER) & FLUNARIZINE DIHYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS : | ||
PROPRANOLOL HYDROCHLORIDE | I.P. | 40 mg | ||
FLURANIZINE (AS EXTENDED RELEASE)) | B.P. | 10 mg | ||
DIHYDROCHLORIDE EQ. TO FLUNARIZINE | ||||
EXCIPIENTS | q.s. | |||
COLOUR : TITANIUM DIOXIDE IP | ||||
51 | ACECLOFENAC, PARACETAMOL & SERRATIOPEPTIDASE TABLETS | EACH FILM COATED TABLET CONTAINS : | ||
ACECLOFENAC | I.P. | 100 mg | ||
PARACETAMOL | I.P. | 325 mg | ||
SERRATIOPEPTIDASE | I.P. | 10 mg | ||
(EQ. TO 20,000 ENZYME ACTIVITY UNITS OF | ||||
EXCIPIENTS | q.s. | |||
COLOUR: TITANIUM DIOXIDE I.P. |
You can download tablets list here.
Sr. No. |
GENERIC NAME |
COMPOSITION |
||
52 |
RABEPRAZOLE SODIUM & LEVOSULPIRIDE SUSTAINED RELEASE CAPSULES |
EACH HARD GELATIN CAPSULE CONTAINS: |
||
RABEPRAZOLE SODIUM |
I.P. |
20 mg |
||
(AS ENTERIC COATED PELLETS) |
||||
LEVOSULPIRIDE |
75 mg |
|||
(AS SUSTAINED RELEASE PELLETS) |
||||
EXCIPIENTS |
q.s. |
|||
APPROVED COLOUR USED IN CAPSULE SHELLS |
||||
53 |
DOMPERIDONE & OMEPRAZOLE CAPSULES |
EACH HARD GELATIN CAPSULES CONTAINS: |
||
DOMPERIDONE |
I.P. |
10 mg |
||
OMEPRAZOLE |
I.P. |
20 mg |
||
(AS ENTERIC COATED GRANULES) |
||||
EXCIPIENTS |
q.s. |
|||
EMPTY GELATIN CAPSULE CONTAINS |
||||
54 |
FLUCONAZOLE CAPSULES I.P. |
EACH HARD GELATIN CAPSULE CONTAINS: |
||
FLUCONAZOLE |
I.P. |
150 mg |
||
EXCIPIENTS |
q.s. |
|||
APPROVED COLOURS USED IN EMPTY |
||||
55 |
CLINDAMYCIN CAPSULES I.P. |
EACH HARD GELATIN CAPSULE CONTAINS: |
||
CLINDAMYCIN HYDROCHLORIDE |
I.P. |
|||
EQ. TO CLINDAMYCIN |
300 mg |
|||
APPROVED COLOURS USED IN EMPTY |
||||
EXCIPIENTS |
q.s. |
|||
56 |
CLINDAMYCIN CAPSULES I.P. |
EACH HARD GELATIN CAPSULE CONTAINS: |
||
CLINDAMYCIN HYDROCHLORIDE |
I.P. |
|||
EQ. TO CLINDAMYCIN |
150 mg |
|||
APPROVED COLOURS USED IN EMPTY |
||||
EXCIPIENTS |
q.s. |
|||
57 |
FERROUS FUMARATE, FOLIC ACID & ZINC SULPHATE MONOHYDRATE CAPSULES |
EACH HARD GELATIN CAPSULES CONTAINS: |
||
FERROUS FUMARATE |
I.P. |
200 mg |
||
EQ. TO ELEMENTAL IRON |
65 mg |
|||
(IN SUSTAINED RELEASE FORM) |
||||
FOLIC ACID |
I.P. |
1000 mcg |
||
CYANOCOBALAMINE(VITAMINB12) |
I.P. |
10.0 mcg |
||
ZINC SULPHATE MONOHYDRATE |
I.P. |
61.8 mg |
||
EQ. TO 22.5mg ELEMENTAL ZINC |
||||
EXCIPIENTS |
q.s. |
|||
APPROVED COLOUR USED IN EMPTY CAPSULE |
||||
(FOR THERAPEUTIC USE) |
||||
58 |
OMEPRAZOLE CAPSULES I.P |
EACH HARD GELATIN CAPSULE CONTAINS: |
||
OMEPRAZOLE |
I.P. |
20 mg |
||
(AS ENTERIC COATED GRANULES) |
||||
EXCIPIENTS |
q.s. |
|||
EMPTY GELATIN CAPSULE CONTAINS |
||||
59 |
RABEPRAZOLE SODIUM & DOMPERIDONE SUSTAINED RELEASE CAPSULES |
EACH HARD GELATIN CAPSULE CONTAINS: |
||
RABEPRAZOLE SODIUM |
I.P. |
20 mg |
||
(AS ENTERIC COATED PELLETS) |
||||
DOMPERIDONE |
I.P. |
30 mg |
||
(AS SUSTAINED RELEASE PELLETS) |
||||
EXICIPIENTS |
q.s. |
|||
APPROVED COLOURS USED IN EMPTY |
||||
60 |
PANTOPRAZOLE SODIUM & DOMPERIDONE SUSTAINED RELEASE CAPSULES |
EACH HARD GELATIN CAPSULE CONTAINS: |
||
PANTOPRAZOLE SODIUM SESQUIHYDRATE |
I.P. |
|||
EQ. TO PANTOPRAZOLE |
40 mg |
|||
(AS ENTERIC COATED PELLETS) |
||||
DOMPERIDONE |
I.P. |
30 mg |
||
(AS SUSTAINED RELEASE PELLETS) |
||||
EXCIPIENTS |
q.s. |
|||
APPROVED COLOURS USED IN CAPSULE SHELL |
||||
61 |
ITRACONAZOLE CAPSULES |
EACH HARD GELATIN CAPSULE CONTAINS : |
||
ITRACONAZOLE PELLETS |
||||
EQ. TO ITRACONAZOLE |
200 mg |
|||
EMPTY GELATIN CAPSULES CONTAIN |
||||
EXCIPIENTS |
q.s. |
|||
APPROVED COLOUR |
||||
62 |
FLUOXETINE HYDROCHLORIDE CAPSULES I.P |
EACH HARD GELATIN CAPSULE CONTAINS: |
||
FLUOXETINE HYDROCHLORIDE |
I.P. |
|||
EQ. TO FLUOXETINE |
20 mg |
|||
EXCIPIENTS |
q.s. |
|||
APPROVED COLOUR USED FOR CAPSULE |
||||
63 |
AMBROXOL, SALBUTAMOL, THEOPHYLINE & N-ACETYL L-CYSTEINE CAPSULES |
EACH HARD GELATIN CAPSULE CONTAINS : |
||
AMBROXOL HYDROCHLORIDE |
I.P. |
30 mg |
||
SALBUTAMOL SULPHATE |
I.P. |
|||
EQ. TO SALBUTAMOL |
2 mg |
|||
THEOPHYLINE (ANHYDROUS) |
I.P. |
100 mg |
||
N-ACETYL-L-CYSTEINE |
I.P. |
50 mg |
||
EXCIPIENTS |
q.s. |
|||
COLOURS USED TARTRAZINE, ERYTHROSINE & |
||||
APPROVED COLOURS USED IN EMPTY |
||||
64 |
ISOTRETINOIN CAPSULES U.S.P. |
EACH HARD GELATIN CAPSULE CONTAINS: |
||
ISOTRETINOIN |
I.P. |
10 mg |
||
EXCIPIENTS |
q.s. |
|||
APPROVED COLOUR USED IN EMPTY CAPSULE |
||||
65 |
ISOTRETINOIN CAPSULES U.S.P. |
EACH HARD GELATIN CAPSULE CONTAINS: |
||
ISOTRETINOIN |
I.P. |
20 mg |
||
EXCIPIENTS |
q.s. |
|||
APPROVED COLOUR USED IN EMPTY CAPSULE |
||||
66 |
SUSTAINED RELEASE PROPRANOLOL HYDROCHLORIDE & FLUNARIZINE DIHYDROCHLORIDE CAPSULES |
EACH HARD GELATIN CAPSULE CONTAINS: |
||
PROPRANOLOL HYDROCHLORIDE |
I.P. |
40 mg |
||
(AS SUSTAINED RELEASE PELLETS) |
||||
FLUNARIZINE DIHYDROCHLORIDE |
B.P. |
|||
EQ. TO FLUNARIZINE |
5 mg |
|||
EXCIPIENTS |
q.s. |
|||
COLOUR : INDIGO CARMINE & BRILLIANT |
||||
APPROVED COLOURS USED IN EMPTY |
||||
67 |
PANTOPRAZOL & LEVOSULPIRIDE SUSTAINED RELEASE CAPSULES |
EACH HARD GELATIN CAPSULE CONTAINS: |
||
PANTOPRAZOLE SODIUM SESQUIHYDRATE |
I.P. |
|||
EQ. TO PANTOPRAZOLE |
40 mg |
|||
(AS ENTERIC COATED PELLETS) |
||||
LEVOSULPIRIDE |
75 mg |
|||
(AS SUSTAINED RELEASE PELLETS) |
||||
EXCIPIENTS |
q.s. |
|||
APPROVED COLOUR USED IN CAPSULE SHELLS |
||||
68 |
ITRACONAZOLE CAPSULES 100 MG |
EACH HARD GELATIN CAPSULE CONTAINS : |
||
ITRACONAZOLE PELLETS |
||||
EQ. TO ITRACONAZOLE |
100 mg |
|||
EMPTY GELATIN CAPSULES CONTAIN |
||||
APPROVED COLOUR |
||||
EXCIPIENTS |
q.s. |
Sr. No. | GENERIC NAME | COMPOSITION | ||
89 | OFLOXACIN, ORNIDAZOLE, TERBINAFINE HYDROCHLORIDE & CLOBETASOL CREAM | |||
OFLOXACIN | I.P. | 0.75 % w/w | ||
ORNIDAZOLE | I.P. | 2.00 % w/w | ||
TERBINAFINE HYDROCHLORIDE | B.P. | 1.00 % w/w | ||
CLOBETASOL PROPIONATE | I.P. | 0.05 % w/w | ||
METHYLPARABEN (AS PRESERVATIVE) | I.P. | 0.20 % w/w | ||
PROPYLPARABEN (AS PRESERVATIVE) | I.P. | 0.02 % w/w | ||
IN CREAM BASE | q.s. | |||
90 | NEOMYCIN SULPHATE, MICONAZOLE NITRATE & FLUOCINOLONE ACETONIDE CREAM | COMPOSITION: | ||
NEOMYCIN SULPHATE | I.P. | 0.5 % w/w | ||
EQ. TO NEOMYCIN | ||||
MICONAZOLE NITRATE | I.P. | 2.0 % w/w | ||
FLUOCINOLONE ACETONIDE | I.P. | 0.025 % w/w | ||
IN A CREAM BASE | q.s. | |||
91 | CLOBETASOL PROPIONATE, MICONAZOLE NITRATE, NEOMYCIN SULPHATE & CHLOROCRESOL CREAM | COMPOSITION: | ||
CLOBETASOL PROPIONATE | I.P. | 0.05 % w/w | ||
MICONAZOLE NITRATE | I.P. | 2.00 % w/w | ||
NEOMYCIN SULPHATE | I.P. | |||
EQ. TO NEOMYCIN | 0.50 % w/w | |||
CHLOROCRESOL | I.P. | 0.10 % w/w | ||
NON GREASY BASE | q.s. | |||
92 | NADIFLOXACIN CREAM 1% w/w | COMPOSITION: | ||
NADIFLOXACIN | 1 % w/w | |||
CREAM BASE | q.s. | |||
93 | MOMETASONE FUROATE CREAM I.P. | COMPOSITION: | ||
MOMETASONE FUROATE | I.P. | 0.1 % w/w | ||
CREAM BASE | q.s. | |||
94 | CLOBETASOL PROPIONATE CREAM I.P. | COMPOSITION: | ||
CLOBETASOL PROPIONATE | I.P. | 0.05 % w/w | ||
CREAM BASE | q.s. | |||
95 | MOMETASONE FUROATE & SALICYCLIC ACID CREAM | COMPOSITION: | ||
MOMETASONE FUROATE | I.P. | 0.1% w/w | ||
SALICYLIC ACID | I.P. | 5.0% w/w | ||
CREAM BASE | q.s. | |||
96 | MOMETASONE FUROATE & FUSIDIC ACID CREAM | COMPOSITION: | ||
MOMETASONE FUROATE | I.P. | 0.1% w/w | ||
FUSIDIC ACID | I.P. | 2.0% w/w | ||
CREAM BASE | q.s. | |||
97 | LULICONAZOLE & CLOBETASOL PROPIONATE CREAM | COMPOSITION: | ||
LULICONAZOLE | 1.0% w/w | |||
CLOBETASOL PROPIONATE | 0.05% w/w | |||
CREAM BASE | q.s. | |||
98 | CLOBETASONE 17-BUTYRATE & GENTAMICIN SULPHATE CREAM | COMPOSITION: | ||
CLOBETASONE 17-BUTYRATE | B.P. | 0.05 % w/w | ||
GENTAMYCIN SULPHATE | I.P. | |||
EQ. TO GENTAMYCIN | 0.10 % w/w | |||
CREAM BASE | q.s. | |||
99 | CLOBETASOL PROPIONATE, CLOTRIMAZOLE & NEOMYCIN SULPHATE CREAM | COMPOSITION: | ||
CLOBETASOL PROPIONATE | I.P. | 0.05% w/w | ||
CLOTRIMAZOLE | I.P. | 1.00% w/w | ||
NEOMYCIN SULPHATE | I.P. | |||
EQ. TO NEOMYCIN BASE | 0.50% w/w | |||
CHLOROCRESOL (AS PRESERVATIVE) | I.P. | 0.10% w/w | ||
CREAM BASE | q.s. | |||
100 | BECLOMETHASONE DIPROPIONATE, NEOMYCIN SULPHATE & CLOTRIMAZOLE CREAM | COMPOSITION: | ||
BECLOMETHASONE DIPROPIONATE | I.P. | 0.025 % w/w | ||
NEOMYCIN SULPHATE | I.P. | 0.5 % w/w | ||
CLOTRIMAZOLE | I.P. | 1.0 % w/w | ||
CHLOROCRESOL(PRESERVATIVE) | I.P. | 0.1 % w/w | ||
CREAM BASE | q.s. | |||
101 | KETOCONAZOLE SHAMPOO | COMPOSITION: | ||
KETOCONAZOLE | I.P. | 2.00 % w/v | ||
AQUEOUS BASE | q.s. | |||
COLOUR : ERYTHROSINE | ||||
102 | ITRACONAZOLE | COMPOSITION: | ||
ITRACONAZOLE | B.P. | 1.00% w/w | ||
METHYL PARABEN | I.P. | 0.10% w/w | ||
PROPYL PARABEN | I.P. | 0.05% w/w | ||
IN A GEL BASE | q.s. | |||
103 | KETOCONAZOLE & BECLOMETHASONE DIPROPIONATE CREAM | COMPOSITION: | ||
KETOCONAZOLE | I.P. | 2.000 % w/w | ||
BECLOMETHASONE DIPROPIONATE | I.P. | 0.025 % w/w | ||
METHYL PARABEN | I.P. | 0.150 % w/w | ||
PROPYL PARABEN | I.P. | 0.500 % w/w | ||
IN CREAM BASE | q.s. | |||
104 | POTASSIUM NITRATE, SODIUM MONOFLUOROPHOSPHATE & TRICLOSAN TOOTHPASTE | COMPOSITION: | ||
POTASSIUM NITRATE | B.P. | 5.0 % w/w | ||
SODIUM MONOFLUOROPHOSPHATE | U.S.P. | 0.7 % w/w | ||
TRICLOSAN | U.S.P. | 0.3 % w/w | ||
IN A PLEASANTLY FLAVOURED BASE | q.s. | |||
AVAILABLE FLUORIDE CONTENT 917 PPM | ||||
COLOUR BRILLIANT BLUE FCF | ||||
105 | MOMETASONE FUROATE & TERBINAFINE HYDROCHLORIDE GEL | COMPOSITION: | ||
MOMETASONE FUROATE | B.P. | 0.10% w/w | ||
TERBINAFINE HYDROCHLORIDE | I.P. | 1.00% w/w | ||
IN A CREAM BASE | q.s. | |||
106 | MOMETASONE FUROATE & TERBINAFINE HYDROCHLORIDE CREAM | COMPOSITION: | ||
MOMETASONE FUROATE | I.P. | 0.10% w/w | ||
TERBINAFINE HYDROCHLORIDE | B.P. | 1.00% w/w | ||
IN A GEL BASE | q.s. | |||
107 | HYDROQUINONE, TRETINOIN & MOMETASONE FUROATE CREAM | COMPOSITIONS: | ||
HYDROQUINONE | U.S.P. | 2.000 % w/w | ||
TRETINOIN | U.S.P. | 0.025 % w/w | ||
MOMETASONE FUROATE | I.P. | 0.100 % w/w | ||
CREAM BASE | q.s. | |||
108 | DICLOFENAC DIETHYLAMINE, OLEUM LINI,METHYL SALICYLATE & MENTHOL GEL | COMPOSITION: | ||
DICLOFENAC DIETHYLAMINE | B.P. | 1.16 % w/w | ||
EQ. TO DICLOFENAC SODIUM | 1.00 % w/w | |||
OLEUM LINI | 3.00 % w/w | |||
(CONT. PREDOMINANTLY a-LINOLENIC ACID) | ||||
METHYL SALICYLATE | I.P. | 10.00 % w/w | ||
MENTHOL | I.P. | 5.00 % w/w | ||
BENZYL ALCOHOL (AS PRESERVATIVE) | I.P. | 1.00 % w/w | ||
GEL BASE | q.s. | |||
109 | DICLOFENAC DIETHYLAMINE, LINSEED OIL, METHYL SALICYLATE, CAPSAICIN & MENTHOL GEL | COMPOSITION: | ||
DICLOFENAC DIETHYLAMINE | B.P. | 1.16 % w/w | ||
EQ. TO DICLOFENAC SODIUM | 1.00 % w/w | |||
LINSEED OIL | B.P. | 3.00 % w/w | ||
METHYL SALICYLATE | I.P. | 10.00 % w/w | ||
CAPSAICIN | 0.025 % w/w | |||
MENTHOL | I.P. | 5.00 % w/w | ||
GEL BASE | q.s. | |||
110 | THYMOL,MENTHOL, ICHTHAMMOL & LIGNOCAINE OINTMENT | COMPOSITION: | ||
THYMOL | I.P. | 0.50 % w/w | ||
ICHTHAMMOL | I.P. | 0.20 % w/w | ||
MENTHOL | I.P. | 1.00 % w/w | ||
LIGNOCAINE | I.P. | 1.00 % w/w | ||
OINTMENT BASE | q.s. | |||
111 | CHLORBUTOL, BENZOCAINE & PARADICHLOROBENZENE EAR DROPS | COMPOSITION: | ||
CHLORBUTOL | I.P. | 5.00 % w/v | ||
BENZOCAINE | I.P. | 2.50 % w/v | ||
PARADICHLOROBENZENE | I.P. | 2.00 % w/v | ||
NON AQUEOUS BASE | q.s. | |||
112 | SUCRALFATE & POVIDONE IODINE OINTMENT | COMPOSITION: | ||
SUCRALFATE | U.S.P. | 7.00 % w/w | ||
POVIDONE IODINE | I.P. | 5.00 % w/w | ||
(AVAILABLE IODINE 0.50 % w/w) | ||||
WATER SOLUBLE OINTMENT BASE | q.s. | |||
WATER SOLUBLE MICROBIAL OINTMENT | ||||
113 | CLINDAMYCIN PHOSPHATE & NICOTINAMIDE GEL | COMPOSITION: | ||
CLINDAMYCIN PHOSPHATE | I.P. | |||
EQ. TO CLINDAMYCIN | 1 % w/w | |||
NICOTINAMIDE | I.P. | 4 % w/w | ||
IN ALOE, ALLANTION BASE WITH ETHYL LACTATE | q.s. | |||
114 | TERBINAFINE HYDROCHLORIDE CREAM | COMPOSITION : | ||
TERBINAFINE HYDROCHLORIDE | B.P. | 1.00 % w/w | ||
BENZYL ALCOHOL (AS PRESERVATIVE) | B.P. | 1.00 % w/w | ||
CREAM BASE | q.s. | |||
115 | PERMETHRIN CREAM | EACH GRAM OF CREAM CONTAINS : | ||
PERMETHRIN | 50 mg | |||
CREAM BASE | q.s. | |||
116 | PERMETHRIN LOTION | COMPOSITION: | ||
PERMETHRIN | 5 % w/v | |||
LOTION BASE | q.s. | |||
COLOUR : SUNSET YELLOW FCF | ||||
117 | LULICONAZOLE CREAM | COMPOSITION: | ||
LULICONAZOLE | 1.0 % w/w | |||
PRESERVATIVE | ||||
BENZYL ALCOHOL | I.P. | 1.0 % w/w | ||
CREAM BASE | q.s. | |||
118 | GAMA BENZENE HEXACHLORIDE & CETRIMIDE LOTION | COMPOSITION: | ||
GAMA BENZENE HEXACHLORIDE | I.P. | 1.0 % w/v | ||
CETRIMIDE | I.P. | 0.1 % w/v | ||
IN AN EMULSION BASE | q.s. |
You can download ointments list here.
Sr. No. |
GENERIC NAME |
COMPOSITION |
||
69 |
IRON WITH VITAMIN B12 & B- COMPLEX SYRUP |
EACH 5ML. CONTAINS : |
||
FERRIC AMMONIUM CITRATE |
I.P |
150 mg |
||
(EQ. TO ELEMENTAL IRON 30 mg) |
||||
CYANOCOBALAMIN |
I.P. |
5.00 mcg |
||
FOLIC ACID |
I.P. |
1.0 mg |
||
ZINC SULPHATE MONOHYDRATE |
I.P. |
|||
EQ TO ELEMENTAL ZINC |
2.75 mg |
|||
FLAVOURED SYRUPY BASE |
q.s. |
|||
COLOUR : CARAMEL I.P. & ERYTHROSINE |
||||
70 |
IRON (III) HYDROXIDE POLYMALTOSE COMPLEX SYRUP |
EACH 5 ML CONTAINS : |
||
IRON(III) HYDROXIDE POLYMALTOSE |
||||
EQ. TO ELEMENTAL IRON |
50 mg |
|||
FLAVOURED SYRUP BASE |
q.s. |
|||
71 |
AZITHROMYCIN ORAL SUSPEN I.P. |
EACH 5 ML CONTAINS: |
||
AZITHROMYCIN DIHYDRATE |
I.P. |
|||
EQ. TO ANHYDROUS AZITHROMYCIN |
200 mg |
|||
FLAVOURED SYRUPY BASE |
q.s. |
|||
COLOUR: QUINOLINE YELLOW |
||||
72 |
FERROUS ASCORBATE & FOLIC ACID SUSPENSION |
EACH 5 ML CONTAINS : |
||
FERROUS ASCORBATE |
||||
EQ. TO ELEMENTAL IRON |
30 mg |
|||
FOLIC ACID |
I.P. |
550 mcg |
||
FLAVORED SYRUPY BASE |
q.s. |
|||
COLOUR : CARAMEL |
||||
73 |
PARACETAMOL, PHENYLEPHRINE HYDROCHLORIDE & CHLORPHENIRAMINE MALEATE SUSPENSION |
EACH ML CONTAINS : |
||
PARACETAMOL |
I.P. |
125 mg |
||
PHENYLEPHRINE HYDROCHLORIDE |
I.P. |
2.5 mg |
||
CHLORPHENIRAMINE MALEATE |
I.P. |
1 mg |
||
EXCIPIENTS |
q.s. |
|||
COLOUR:PONCEAU 4R |
||||
74 |
TERBUTALINE, BROMHEXINE HYDROCHLORIDE, GUAIPHENESIN & MENTHOL SYRUP |
EACH 5ML CONTAINS: |
||
TERBUTALINE SULPHATE |
I.P. |
1.25 mg |
||
BROMHEXINE HYDROCHLORIDE |
I.P. |
2 mg |
||
GUAIPHENESIN |
I.P. |
50 mg |
||
MENTHOL |
I.P. |
0.5 mg |
||
FALVOURED SYRUP BASE |
q.s. |
|||
COLOUR : SUNSET YELLOW FCF & |
||||
75 |
DIPHENHYDRAMINE HYDROCHLORIDE, AMMONIUM CHLORIDE, SODIUM CITRATE & MENTHOL SYRUP |
EACH 5ML CONTAINS: |
||
DIPHENHYDRAMINE HYDROCHLORIDE |
I.P. |
14.08 mg |
||
AMMONIUM CHLORIDE |
I.P. |
138 mg |
||
SODIUM CITRATE |
I.P. |
100 mg |
||
MENTHOL |
I.P. |
1.14 mg |
||
FLAVOURED SYRUP BASE |
q.s. |
|||
COLOUR: CARAMEL |
||||
76 |
SILYMARIN SUSPENSION |
EACH 5ML CONTAINS: |
||
SILYMARIN (AS SILYBIN) |
35 mg |
|||
FLAVOURED SYRUP BASE |
q.s. |
|||
COLOUR: SUNSET YELLOW FCF |
||||
77 |
CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE SYRUP |
EACH 5 ML CONTAINS: |
||
CHLORPHENIRAMINE MALEATE |
I.P. |
2 mg |
||
DEXTROMETHORPHAN HYDROBROMIDE |
I.P. |
10 mg |
||
PHENYLEPHRINE HYDROCHLORIDE |
I.P. |
5 mg |
||
IN FLAVOURED SYRUP BASE |
q.s. |
|||
COLOUR: BRILLIANT BLUE FCF & TARTRAZINE |
||||
78 |
AMBROXOL HYDROCLORIDE, GUAIPHENESIN & PHENYLEPHRINE HYDROCLORIDE SYRUP |
EACH 5 ML CONTAINS: |
||
AMBROXOL HYDROCLORIDE |
I.P. |
15 mg |
||
GUAIPHENESIN |
I.P. |
50 mg |
||
PHENYLEPHRINE HYDROCLORIDE |
I.P. |
2.5 mg |
||
IN A FLAVOURED SYP BASE |
q.s. |
|||
COLOUR: SUNSET YELLOW FCF |
||||
79 |
LEVOSALBUTAMOL SULPHATE, AMBROXOL HYDROCHLORIDE & GUAIPHENESIN SYRUP |
EACH 5ML CONTAINS : |
||
LEVOSALBUTAMOL SULPHATE |
I.P |
0.5 mg |
||
AMBROXOL HYDROCHLORIDE |
I.P. |
15 mg |
||
GUAIPHENESIN |
I.P. |
50 mg |
||
FLAVOURED SYRUP BASE |
q.s. |
|||
COLOUR : PONCEAU 4R |
||||
80 |
DISODIUM HYDROGEN CITRATE SYRUP |
EACH 5 ML CONTAINS: |
||
DISODIUM HYDROGEN CITRATE |
B.P. |
1.53 gm |
||
FLAVOURED SYRUP BASE |
q.s. |
|||
COLOUR: TARTRAZINE & ERYTHROSINE |
||||
81 |
MEFENAMIC ACID & PARACETAMOL ORAL SUSPENSION |
EACH 5 ML CONTAINS : |
||
MEFENAMIC ACID |
I.P. |
50 mg |
||
PARACETAMOL |
I.P. |
125 mg |
||
FLAVOURED SYRUPY BASE |
q.s. |
|||
COLOUR : SUNSET YELLOW FCF |
Sr. No. |
GENERIC NAME |
COMPOSITION |
||
1 |
TRAMADOL HYDRCHLORIDE & PARACETAMOL TABLETS U.S.P. |
EACH FILM COATED TABLET CONTAINS : |
||
PARACETAMOL |
I.P. |
325 mg |
||
TRAMADOL HYDROCHLORIDE |
I.P. |
50 mg |
||
EXCIPIENTS |
q.s. |
|||
COLOUR : YELLOW ODIXE OF IRON & TITANIUM DIOXIDE I.P. |
||||
2 |
PANTOPRAZOLE & DOMPERIDONE TABLETS |
EACH ENTERIC COATED TABLET CONTAINS: |
||
PANTOPRAZOLE SODIUM SESQUIHYDRATE |
I.P. |
|||
EQ. TO PANTOPRAZOLE |
40 mg |
|||
DOMPERIDONE |
I.P. |
10 mg |
||
EXCIPIENTS |
q.s. |
|||
COLOUR : SUNSET YELLOW FCF |
||||
3 |
LEVOCETIRIZINE DIHYDROCHLORIDE, PHENYLEPHRINE HYDROCHLORIDE & PARACETAMOL TABLET |
EACH UNCOATED TABLET CONTAINS: |
||
LEVOCETIRIZINE DIHYDROCHLORIDE |
I.P. |
5 mg |
||
PHENYLEPHRINE HYDROCHLORIDE |
I.P. |
5 mg |
||
PARACETAMOL |
I.P. |
325 mg |
||
EXCIPIENTS |
q.s. |
|||
COLOUR : QUINOLINE YELLOW WS & BRILLIANT BLUE FCF |
||||
4 |
DICLOFENAC SODIUM & PARACETAMOL TABLETS |
EACH UNCOATED TABLET CONTAINS : |
||
DICLOFENAC SODIUM |
I.P. |
50 mg |
||
PARACETAMOL |
I.P. |
325 mg |
||
EXCIPIENTS |
q.s. |
|||
COLOUR : SUNSET YELLOW FCF |
||||
5 |
RISPERIDONE & TRIHEXYPHENIDYL HYDROCHLORIDE TABLETS |
EACH UNCOATED TABLET CONTAINS : |
||
RISPERIDONE |
B.P. |
2 mg |
||
TRIHEXYPHENIDYL HYDROCHLORIDE |
B.P. |
2 mg |
||
EXCIPIENTS |
q.s. |
|||
6 |
CLONAZEPAM & PROPRANOLOL HYDROCHLORIDE TABLETS |
EACH UNCOATED TABLET CONTAINS : |
||
CLONAZEPAM |
I.P. |
0.25 mg |
||
PROPRANOLOL HYDROCHLORIDE |
I.P. |
10 mg |
||
EXCIPIENTS |
q.s. |
|||
7 |
CLONAZEPAM & PROPRANOLOL HYDROCHLORIDE TABLETS |
EACH UNCOATED TABLET CONTAINS : |
||
CLONAZEPAM |
I.P. |
0.5 mg |
||
PROPRANOLOL HYDROCHLORIDE |
I.P. |
20 mg |
||
EXCIPIENTS |
q.s. |
|||
8 |
CLONAZEPAM & PROPRANOLOL HYDROCHLORIDE TABLETS |
EACH UNCOATED TABLET CONTAINS : |
||
CLONAZEPAM |
I.P. |
0.5 mg |
||
PROPRANOLOL HYDROCHLORIDE |
I.P. |
10 mg |
||
EXCIPIENTS |
q.s. |
|||
9 |
LEVOCETIRIZINE DIHYDROCHLORIDE TABLETS I.P |
EACH FILM COATED TABLET CONTAINS: |
||
LEVOCETIRIZINE DIHYDROCHLORIDE |
I.P. |
5 mg |
||
EXCIPIENTS |
q.s. |
|||
COLOUR: TITANIUM DIOXIDE IP |
||||
10 |
PYRIDOXINE HYDROCHLORIDE TABLETS IP |
EACH UNCOATED TABLET CONTAINS : |
||
PYRIDOXINE HYDROCHLORIDE |
I.P. |
50 mg |
||
EXCIPIENTS |
q.s. |
|||
11 |
LORAZEPAM TABLETS I.P. |
EACH UNCOATED MOUTH DISSOLVING TABLET CONTAINS: |
||
LORAZEPAM |
I.P. |
3.0 mg |
||
EXCIPIENTS |
q.s. |
|||
12 |
CIPROFLOXACIN HYDROCHLORIDE TABLETS IP |
EACH FILM COATED TABLET CONTAINS: |
||
CIPROFLOXACIN HYDROCHLORIDE |
I.P. |
|||
EQ. to CIPROFLOXACIN |
500 mg |
|||
EXCIPIENTS |
q.s. |
|||
COLOUR : TITANIUM DIOXIDE IP |
||||
13 |
CIPROFLOXACIN HYDROCHLORIDE TABLETS IP |
EACH FILM COATED TABLET CONTAINS: |
||
CIPROFLOXACIN HYDROCHLORIDE |
I.P. |
|||
EQ. to CIPROFLOXACIN |
250 mg |
|||
EXCIPIENTS |
q.s. |
|||
COLOUR : TITANIUM DIOXIDE IP |
||||
14 |
ACECLOFENAC & PARACETAMOL TABLETS |
EACH FILM COATED TABLET CONTAINS: |
||
ACECLOFENAC |
I.P. |
100 mg |
||
PARACETAMOL |
I.P. |
325 mg |
||
EXCIPIENTS |
q.s. |
|||
COLOUR: TITANIUM DIOXIDE I.P. |
||||
15 |
NIMESULIDE & PARACETAMOL TAB |
EACH UNCOATED TABLET CONTAINS : |
||
NIMESULIDE |
B.P. |
100 mg |
||
PARACETAMOL |
I.P. |
325 mg |
||
EXCIPIENTS |
q.s. |
|||
(NOT FOR CHILDREN BELOW 12 YEARS) |
||||
16 |
PARACETAMOL, PHELYEPHRINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE & CAFFEINE TABLET |
EACH UNCOATED TABLET CONTAINS : |
||
PARACETAMOL |
I.P. |
325 mg |
||
PHENYLEPHRINE HYDROCHLORIDE |
I.P. |
25 mg |
||
DIPHENHYDRAMINE HYDROCHLORIDE |
5 mg |
|||
CAFFEINE |
I.P. |
30 mg |
||
EXCEPIENTS |
q.s. |
|||
COLOUR : SUNSET YELLOW FCF |
||||
17 |
PANTOPRAZOLE TABLET I.P. |
EACH ENTERIC COATED TABLET CONTAINS: |
||
PANTOPRAZOLE SODIUM SESQUIHYDRATE |
I.P. |
|||
EQ. TO PANTOPRAZOLE |
40 mg |
|||
EXCIPIENTS |
q.s. |
|||
COLOUR:TITANIUM DIOXIDE I.P. |
||||
18 |
MONTELUKAST SODIUM & LEVOCETIRIZINE DIHYDROCHLORIDE TABLET |
EACH FILM COATED TABLET CONTAINS: |
||
MONTELUKAST SODIUM |
I.P. |
|||
Eq. TO MONTELUKAST |
10 mg |
|||
LEVOCETIRIZINE DIHYDROCHLORIDE |
I.P. |
5 mg |
||
EXCIPIENTS |
q.s. |
|||
COLOUR: TITANIUM DIOXIDE I.P. |
||||
19 |
CETIRIZINE DIHYDROCHLORIDE, PARACETAMOL, PHENYLEPHRINE HYDROCHLORIDE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
||
CETIRIZINE DIHYDROCHLORIDE |
I.P. |
5 mg |
||
PARACETAMOL |
I.P. |
325 mg |
||
PHENYLEPHRINE HYDROCHLORIDE |
I.P. |
10 mg |
||
EXCIPIENTS |
q.s. |
|||
COLOUR: SUNSET YELLOW FCF |
||||
20 |
CETIRIZINE DIHYDROCHLORIDE, PARACETAMOL, PHENYLEPHRINE HYDROCHLORIDE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
||
CETIRIZINE DIHYDROCHLORIDE |
I.P. |
5 mg |
||
PARACETAMOL |
I.P. |
325 mg |
||
PHENYLEPHRINE HYDROCHLORIDE |
I.P. |
5 mg |
||
EXCIPIENTS |
q.s. |
|||
COLOUR: SUNSET YELLOW FCF |
||||
21 |
TERBINAFINE HYDROCHLORIDE TABLET |
EACH UNCOATED TABLET CONTAINS : |
||
TERBINAFINE HYDROCHLORIDE |
B.P. |
|||
E.Q. TO TERBINAFINE |
500 mg |
|||
(IN BETACYCLODEXTRIN) |
||||
EXCIPIENTS |
q.s. |
|||
22 |
TERBINAFINE HYDROCHLORIDE TABLET U.S.P |
EACH UNCOATED TABLET CONTAINS : |
||
TERBINAFINE HYDROCHLORIDE |
B.P. |
|||
E.Q. TO TERBINAFINE |
250 mg |
|||
(IN BETACYCLODEXTRIN) |
||||
EXCIPIENTS |
q.s. |
|||
23 |
DICLOFENAC POTASSIUM, PARACETAMOL TABLETS |
EACH UNCOATED TABLET CONTAINS: |
||
DICLOFENAC POTASSIUM |
B.P. |
50 mg |
||
PARACETAMOL |
I.P. |
325 mg |
||
EXCIPIENTS |
q.s. |
|||
COLOUR:ERYTHROSINE |
||||
24 |
DICLOFENAC SODIUM, CHLORZOXAZONE & PARACETAMOL TABLETS |
EACH UNCOATED TABLET CONTAINS: |
||
DICLOFENAC SODIUM |
I.P. |
50 mg |
||
PARACETAMOL |
I.P. |
325 mg |
||
CHLORZOXAZONE |
U.S.P. |
250 mg |
||
EXCIPIENTS |
q.s. |
|||
25 |
ONDANSETRON ORALLY DISINTEGRATING TABLETS I.P. |
EACH UNCOATED ORALLY DISINTEGRATING TABLET CONTAINS: |
||
ONDANSETRON HYDROCHLORIDE |
I.P. |
|||
E.Q. TO ONDANSETRON |
4 mg |
|||
EXCIPIENTS |
q.s. |
|||
COLOUR: ERYTHROSINE |
||||
26 |
ARTEMETHER & LUMEFANTRINE TABLETS |
EACH UNCOATED TABLET CONTAINS: |
||
ARTEMETHER |
IP |
80 mg |
||
LUMEFANTRINE |
BP |
480 mg |
||
EXCIPIENTS |
q.s. |
|||
COLOUR : TARTRAZINE |
||||
27 |
AZITHROMYCIN DIHYDRATE TABLETS I.P. |
EACH FILM COATED TABLET CONTAINS: |
||
AZITHROMYCIN DIHYDRATE |
I.P. |
|||
EQ. TO ANHYDROUS AZITHROMYCIN |
250 mg |
|||
EXCIPIENTS |
q.s. |
|||
COLOUR: TARTRAZINE LAKE |
||||
28 |
AZITHROMYCIN DIHYDRATE TABLETS I.P. |
EACH FILM COATED TABLET CONTAINS: |
||
AZITHROMYCIN DIHYDRATE |
I.P. |
|||
EQ. TO ANHYDROUS AZITHROMYCIN |
500 mg |
|||
EXCIPIENTS |
q.s. |
|||
COLOUR: TITANIUM DIOXIDEI.P. |
||||
29 |
DEFLAZACORT TABLETS |
EACH UNCOATED TABLET CONTAINS: |
||
DEFLAZACORT |
6 mg |
|||
EXCIPIENTS |
q.s. |
|||
30 |
FLUVOXAMINE MELEATE SUSTAINED RELEASE TABLETS |
EACH UNCOATED SR TABLET CONTAINS: |
||
FLUVOXAMINE MELEATE |
B.P. |
100 mg |
||
EXCIPIENTS |
q.s. |
|||
31 |
FLUCONAZOLE TABLETS I.P. |
EACH UNCOATED TABLET CONTAINS: |
||
FLUCONAZOLE |
I.P. |
150 mg |
||
EXCIPIENTS |
q.s. |
|||
COLOUR: PONCEAU 4R |
||||
32 |
ETIZOLAM TABLETS |
EACH FILM COATED TABLET CONTAINS: |
||
ETIZOLAM |
I.P. |
0.5 mg |
||
EXCIPIENTS |
q.s. |
|||
COLOUR: TITANIUM DIOXIDE I.P. |
||||
33 |
FLUCONAZOLE TABLETS I.P. |
EACH UNCOATED TABLET CONTAINS: |
||
FLUCONAZOLE |
I.P. |
200 mg |
||
EXCIPIENTS |
q.s. |
|||
34 |
FLUCONAZOLE TABLETS I.P. |
EACH UNCOATED TABLET CONTAINS: |
||
FLUCONAZOLE |
I.P. |
300 mg |
||
EXCIPIENTS |
q.s. |
|||
35 |
FLUCONAZOLE TABLETS I.P. |
EACH UNCOATED TABLET CONTAINS: |
||
FLUCONAZOLE |
I.P. |
400 mg |
||
EXCIPIENTS |
q.s. |
|||
45 |
ETORICOXIB TABLETS |
EACH FILM COATED TABLET CONTAINS |
||
ETORICOXIB |
I.P. |
90 mg |
||
EXCIPIENTS |
q.s. |
|||
COLOUR: RED OXIDE OF IRON & TITANIUM DIOXIDE I.P. |
||||
46 |
ETODOLAC & PARACETAMOL TABLETS |
EACH FILM COATED TABLET CONTAINS |
||
ETODOLAC |
I.P. |
400 mg |
||
PARACETAMOL |
I.P. |
325 mg |
||
EXCIPIENTS |
q.s. |
|||
COLOUR SUNSET YELLOW FCF |
||||
47 |
ETORICOXIB & THIOCOLCHICOSIDE TABLETS |
EACH FILM COATED TABLET CONTAINS |
||
ETORICOXIB |
I.P. |
60 mg |
||
THIOCOLCHICOSIDE |
I.P. |
4 mg |
||
EXCIPIENTS |
q.s. |
|||
COLOUR: RED OXIDE OF IRON & TITANIUM DIOXIDE I.P. |
||||
48 |
NORTRIPTYLINE TABLETS I.P. |
EACH FILM COATED TABLET CONTAINS |
||
NORTRIPTYLINE HYDROCHLORIDE |
I.P. |
10 mg |
||
EQ. TO NORTRIPTYLINE |
||||
EXCIPIENTS |
q.s. |
|||
COLOUR : TITANIUM DIOXIDE IP |
||||
49 |
KETOCONAZOLE TABLETS I.P. |
EACH UNCOATED TABLET CONTAINS: |
||
KETOCONAZOLE |
I.P. |
200 mg |
||
EXCIPIENTS |
q.s. |
|||
50 |
PROPRANOLOL HYDROCHLORIDE (ER) & FLUNARIZINE DIHYDROCHLORIDE TABLETS |
EACH FILM COATED TABLET CONTAINS : |
||
PROPRANOLOL HYDROCHLORIDE |
I.P. |
40 mg |
||
FLURANIZINE (AS EXTENDED RELEASE)) |
B.P. |
10 mg |
||
DIHYDROCHLORIDE EQ. TO FLUNARIZINE |
||||
EXCIPIENTS |
q.s. |
|||
COLOUR : TITANIUM DIOXIDE IP |
||||
51 |
ACECLOFENAC, PARACETAMOL & SERRATIOPEPTIDASE TABLETS |
EACH FILM COATED TABLET CONTAINS : |
||
ACECLOFENAC |
I.P. |
100 mg |
||
PARACETAMOL |
I.P. |
325 mg |
||
SERRATIOPEPTIDASE |
I.P. |
10 mg |
||
(EQ. TO 20,000 ENZYME ACTIVITY UNITS OF |
||||
EXCIPIENTS |
q.s. |
|||
COLOUR: TITANIUM DIOXIDE I.P. |
Sr. No. |
GENERIC NAME |
COMPOSITION |
||
52 |
RABEPRAZOLE SODIUM & LEVOSULPIRIDE SUSTAINED RELEASE CAPSULES |
EACH HARD GELATIN CAPSULE CONTAINS: |
||
RABEPRAZOLE SODIUM |
I.P. |
20 mg |
||
(AS ENTERIC COATED PELLETS) |
||||
LEVOSULPIRIDE |
75 mg |
|||
(AS SUSTAINED RELEASE PELLETS) |
||||
EXCIPIENTS |
q.s. |
|||
APPROVED COLOUR USED IN CAPSULE SHELLS |
||||
53 |
DOMPERIDONE & OMEPRAZOLE CAPSULES |
EACH HARD GELATIN CAPSULES CONTAINS: |
||
DOMPERIDONE |
I.P. |
10 mg |
||
OMEPRAZOLE |
I.P. |
20 mg |
||
(AS ENTERIC COATED GRANULES) |
||||
EXCIPIENTS |
q.s. |
|||
EMPTY GELATIN CAPSULE CONTAINS |
||||
54 |
FLUCONAZOLE CAPSULES I.P. |
EACH HARD GELATIN CAPSULE CONTAINS: |
||
FLUCONAZOLE |
I.P. |
150 mg |
||
EXCIPIENTS |
q.s. |
|||
APPROVED COLOURS USED IN EMPTY |
||||
55 |
CLINDAMYCIN CAPSULES I.P. |
EACH HARD GELATIN CAPSULE CONTAINS: |
||
CLINDAMYCIN HYDROCHLORIDE |
I.P. |
|||
EQ. TO CLINDAMYCIN |
300 mg |
|||
APPROVED COLOURS USED IN EMPTY |
||||
EXCIPIENTS |
q.s. |
|||
56 |
CLINDAMYCIN CAPSULES I.P. |
EACH HARD GELATIN CAPSULE CONTAINS: |
||
CLINDAMYCIN HYDROCHLORIDE |
I.P. |
|||
EQ. TO CLINDAMYCIN |
150 mg |
|||
APPROVED COLOURS USED IN EMPTY |
||||
EXCIPIENTS |
q.s. |
|||
57 |
FERROUS FUMARATE, FOLIC ACID & ZINC SULPHATE MONOHYDRATE CAPSULES |
EACH HARD GELATIN CAPSULES CONTAINS: |
||
FERROUS FUMARATE |
I.P. |
200 mg |
||
EQ. TO ELEMENTAL IRON |
65 mg |
|||
(IN SUSTAINED RELEASE FORM) |
||||
FOLIC ACID |
I.P. |
1000 mcg |
||
CYANOCOBALAMINE(VITAMINB12) |
I.P. |
10.0 mcg |
||
ZINC SULPHATE MONOHYDRATE |
I.P. |
61.8 mg |
||
EQ. TO 22.5mg ELEMENTAL ZINC |
||||
EXCIPIENTS |
q.s. |
|||
APPROVED COLOUR USED IN EMPTY CAPSULE |
||||
(FOR THERAPEUTIC USE) |
||||
58 |
OMEPRAZOLE CAPSULES I.P |
EACH HARD GELATIN CAPSULE CONTAINS: |
||
OMEPRAZOLE |
I.P. |
20 mg |
||
(AS ENTERIC COATED GRANULES) |
||||
EXCIPIENTS |
q.s. |
|||
EMPTY GELATIN CAPSULE CONTAINS |
||||
59 |
RABEPRAZOLE SODIUM & DOMPERIDONE SUSTAINED RELEASE CAPSULES |
EACH HARD GELATIN CAPSULE CONTAINS: |
||
RABEPRAZOLE SODIUM |
I.P. |
20 mg |
||
(AS ENTERIC COATED PELLETS) |
||||
DOMPERIDONE |
I.P. |
30 mg |
||
(AS SUSTAINED RELEASE PELLETS) |
||||
EXICIPIENTS |
q.s. |
|||
APPROVED COLOURS USED IN EMPTY |
||||
60 |
PANTOPRAZOLE SODIUM & DOMPERIDONE SUSTAINED RELEASE CAPSULES |
EACH HARD GELATIN CAPSULE CONTAINS: |
||
PANTOPRAZOLE SODIUM SESQUIHYDRATE |
I.P. |
|||
EQ. TO PANTOPRAZOLE |
40 mg |
|||
(AS ENTERIC COATED PELLETS) |
||||
DOMPERIDONE |
I.P. |
30 mg |
||
(AS SUSTAINED RELEASE PELLETS) |
||||
EXCIPIENTS |
q.s. |
|||
APPROVED COLOURS USED IN CAPSULE SHELL |
||||
61 |
ITRACONAZOLE CAPSULES |
EACH HARD GELATIN CAPSULE CONTAINS : |
||
ITRACONAZOLE PELLETS |
||||
EQ. TO ITRACONAZOLE |
200 mg |
|||
EMPTY GELATIN CAPSULES CONTAIN |
||||
EXCIPIENTS |
q.s. |
|||
APPROVED COLOUR |
||||
62 |
FLUOXETINE HYDROCHLORIDE CAPSULES I.P |
EACH HARD GELATIN CAPSULE CONTAINS: |
||
FLUOXETINE HYDROCHLORIDE |
I.P. |
|||
EQ. TO FLUOXETINE |
20 mg |
|||
EXCIPIENTS |
q.s. |
|||
APPROVED COLOUR USED FOR CAPSULE |
||||
63 |
AMBROXOL, SALBUTAMOL, THEOPHYLINE & N-ACETYL L-CYSTEINE CAPSULES |
EACH HARD GELATIN CAPSULE CONTAINS : |
||
AMBROXOL HYDROCHLORIDE |
I.P. |
30 mg |
||
SALBUTAMOL SULPHATE |
I.P. |
|||
EQ. TO SALBUTAMOL |
2 mg |
|||
THEOPHYLINE (ANHYDROUS) |
I.P. |
100 mg |
||
N-ACETYL-L-CYSTEINE |
I.P. |
50 mg |
||
EXCIPIENTS |
q.s. |
|||
COLOURS USED TARTRAZINE, ERYTHROSINE & |
||||
APPROVED COLOURS USED IN EMPTY |
||||
64 |
ISOTRETINOIN CAPSULES U.S.P. |
EACH HARD GELATIN CAPSULE CONTAINS: |
||
ISOTRETINOIN |
I.P. |
10 mg |
||
EXCIPIENTS |
q.s. |
|||
APPROVED COLOUR USED IN EMPTY CAPSULE |
||||
65 |
ISOTRETINOIN CAPSULES U.S.P. |
EACH HARD GELATIN CAPSULE CONTAINS: |
||
ISOTRETINOIN |
I.P. |
20 mg |
||
EXCIPIENTS |
q.s. |
|||
APPROVED COLOUR USED IN EMPTY CAPSULE |
||||
66 |
SUSTAINED RELEASE PROPRANOLOL HYDROCHLORIDE & FLUNARIZINE DIHYDROCHLORIDE CAPSULES |
EACH HARD GELATIN CAPSULE CONTAINS: |
||
PROPRANOLOL HYDROCHLORIDE |
I.P. |
40 mg |
||
(AS SUSTAINED RELEASE PELLETS) |
||||
FLUNARIZINE DIHYDROCHLORIDE |
B.P. |
|||
EQ. TO FLUNARIZINE |
5 mg |
|||
EXCIPIENTS |
q.s. |
|||
COLOUR : INDIGO CARMINE & BRILLIANT |
||||
APPROVED COLOURS USED IN EMPTY |
||||
67 |
PANTOPRAZOL & LEVOSULPIRIDE SUSTAINED RELEASE CAPSULES |
EACH HARD GELATIN CAPSULE CONTAINS: |
||
PANTOPRAZOLE SODIUM SESQUIHYDRATE |
I.P. |
|||
EQ. TO PANTOPRAZOLE |
40 mg |
|||
(AS ENTERIC COATED PELLETS) |
||||
LEVOSULPIRIDE |
75 mg |
|||
(AS SUSTAINED RELEASE PELLETS) |
||||
EXCIPIENTS |
q.s. |
|||
APPROVED COLOUR USED IN CAPSULE SHELLS |
||||
68 |
ITRACONAZOLE CAPSULES 100 MG |
EACH HARD GELATIN CAPSULE CONTAINS : |
||
ITRACONAZOLE PELLETS |
||||
EQ. TO ITRACONAZOLE |
100 mg |
|||
EMPTY GELATIN CAPSULES CONTAIN |
||||
APPROVED COLOUR |
||||
EXCIPIENTS |
q.s. |
Sr. No. |
GENERIC NAME |
COMPOSITION |
||
89 |
OFLOXACIN, ORNIDAZOLE, TERBINAFINE HYDROCHLORIDE & CLOBETASOL CREAM |
|||
OFLOXACIN |
I.P. |
0.75 % w/w |
||
ORNIDAZOLE |
I.P. |
2.00 % w/w |
||
TERBINAFINE HYDROCHLORIDE |
B.P. |
1.00 % w/w |
||
CLOBETASOL PROPIONATE |
I.P. |
0.05 % w/w |
||
METHYLPARABEN (AS PRESERVATIVE) |
I.P. |
0.20 % w/w |
||
PROPYLPARABEN (AS PRESERVATIVE) |
I.P. |
0.02 % w/w |
||
IN CREAM BASE |
q.s. |
|||
90 |
NEOMYCIN SULPHATE, MICONAZOLE NITRATE & FLUOCINOLONE ACETONIDE CREAM |
COMPOSITION: |
||
NEOMYCIN SULPHATE |
I.P. |
0.5 % w/w |
||
EQ. TO NEOMYCIN |
||||
MICONAZOLE NITRATE |
I.P. |
2.0 % w/w |
||
FLUOCINOLONE ACETONIDE |
I.P. |
0.025 % w/w |
||
IN A CREAM BASE |
q.s. |
|||
91 |
CLOBETASOL PROPIONATE, MICONAZOLE NITRATE, NEOMYCIN SULPHATE & CHLOROCRESOL CREAM |
COMPOSITION: |
||
CLOBETASOL PROPIONATE |
I.P. |
0.05 % w/w |
||
MICONAZOLE NITRATE |
I.P. |
2.00 % w/w |
||
NEOMYCIN SULPHATE |
I.P. |
|||
EQ. TO NEOMYCIN |
0.50 % w/w |
|||
CHLOROCRESOL |
I.P. |
0.10 % w/w |
||
NON GREASY BASE |
q.s. |
|||
92 |
NADIFLOXACIN CREAM 1% w/w |
COMPOSITION: |
||
NADIFLOXACIN |
1 % w/w |
|||
CREAM BASE |
q.s. |
|||
93 |
MOMETASONE FUROATE CREAM I.P. |
COMPOSITION: |
||
MOMETASONE FUROATE |
I.P. |
0.1 % w/w |
||
CREAM BASE |
q.s. |
|||
94 |
CLOBETASOL PROPIONATE CREAM I.P. |
COMPOSITION: |
||
CLOBETASOL PROPIONATE |
I.P. |
0.05 % w/w |
||
CREAM BASE |
q.s. |
|||
95 |
MOMETASONE FUROATE & SALICYCLIC ACID CREAM |
COMPOSITION: |
||
MOMETASONE FUROATE |
I.P. |
0.1% w/w |
||
SALICYLIC ACID |
I.P. |
5.0% w/w |
||
CREAM BASE |
q.s. |
|||
96 |
MOMETASONE FUROATE & FUSIDIC ACID CREAM |
COMPOSITION: |
||
MOMETASONE FUROATE |
I.P. |
0.1% w/w |
||
FUSIDIC ACID |
I.P. |
2.0% w/w |
||
CREAM BASE |
q.s. |
|||
97 |
LULICONAZOLE & CLOBETASOL PROPIONATE CREAM |
COMPOSITION: |
||
LULICONAZOLE |
1.0% w/w |
|||
CLOBETASOL PROPIONATE |
0.05% w/w |
|||
CREAM BASE |
q.s. |
|||
98 |
CLOBETASONE 17-BUTYRATE & GENTAMICIN SULPHATE CREAM |
COMPOSITION: |
||
CLOBETASONE 17-BUTYRATE |
B.P. |
0.05 % w/w |
||
GENTAMYCIN SULPHATE |
I.P. |
|||
EQ. TO GENTAMYCIN |
0.10 % w/w |
|||
CREAM BASE |
q.s. |
|||
99 |
CLOBETASOL PROPIONATE, CLOTRIMAZOLE & NEOMYCIN SULPHATE CREAM |
COMPOSITION: |
||
CLOBETASOL PROPIONATE |
I.P. |
0.05% w/w |
||
CLOTRIMAZOLE |
I.P. |
1.00% w/w |
||
NEOMYCIN SULPHATE |
I.P. |
|||
EQ. TO NEOMYCIN BASE |
0.50% w/w |
|||
CHLOROCRESOL (AS PRESERVATIVE) |
I.P. |
0.10% w/w |
||
CREAM BASE |
q.s. |
|||
100 |
BECLOMETHASONE DIPROPIONATE, NEOMYCIN SULPHATE & CLOTRIMAZOLE CREAM |
COMPOSITION: |
||
BECLOMETHASONE DIPROPIONATE |
I.P. |
0.025 % w/w |
||
NEOMYCIN SULPHATE |
I.P. |
0.5 % w/w |
||
CLOTRIMAZOLE |
I.P. |
1.0 % w/w |
||
CHLOROCRESOL(PRESERVATIVE) |
I.P. |
0.1 % w/w |
||
CREAM BASE |
q.s. |
|||
101 |
KETOCONAZOLE SHAMPOO |
COMPOSITION: |
||
KETOCONAZOLE |
I.P. |
2.00 % w/v |
||
AQUEOUS BASE |
q.s. |
|||
COLOUR : ERYTHROSINE |
||||
102 |
ITRACONAZOLE |
COMPOSITION: |
||
ITRACONAZOLE |
B.P. |
1.00% w/w |
||
METHYL PARABEN |
I.P. |
0.10% w/w |
||
PROPYL PARABEN |
I.P. |
0.05% w/w |
||
IN A GEL BASE |
q.s. |
|||
103 |
KETOCONAZOLE & BECLOMETHASONE DIPROPIONATE CREAM |
COMPOSITION: |
||
KETOCONAZOLE |
I.P. |
2.000 % w/w |
||
BECLOMETHASONE DIPROPIONATE |
I.P. |
0.025 % w/w |
||
METHYL PARABEN |
I.P. |
0.150 % w/w |
||
PROPYL PARABEN |
I.P. |
0.500 % w/w |
||
IN CREAM BASE |
q.s. |
|||
104 |
POTASSIUM NITRATE, SODIUM MONOFLUOROPHOSPHATE & TRICLOSAN TOOTHPASTE |
COMPOSITION: |
||
POTASSIUM NITRATE |
B.P. |
5.0 % w/w |
||
SODIUM MONOFLUOROPHOSPHATE |
U.S.P. |
0.7 % w/w |
||
TRICLOSAN |
U.S.P. |
0.3 % w/w |
||
IN A PLEASANTLY FLAVOURED BASE |
q.s. |
|||
AVAILABLE FLUORIDE CONTENT 917 PPM |
||||
COLOUR BRILLIANT BLUE FCF |
||||
105 |
MOMETASONE FUROATE & TERBINAFINE HYDROCHLORIDE GEL |
COMPOSITION: |
||
MOMETASONE FUROATE |
B.P. |
0.10% w/w |
||
TERBINAFINE HYDROCHLORIDE |
I.P. |
1.00% w/w |
||
IN A CREAM BASE |
q.s. |
|||
106 |
MOMETASONE FUROATE & TERBINAFINE HYDROCHLORIDE CREAM |
COMPOSITION: |
||
MOMETASONE FUROATE |
I.P. |
0.10% w/w |
||
TERBINAFINE HYDROCHLORIDE |
B.P. |
1.00% w/w |
||
IN A GEL BASE |
q.s. |
|||
107 |
HYDROQUINONE, TRETINOIN & MOMETASONE FUROATE CREAM |
COMPOSITIONS: |
||
HYDROQUINONE |
U.S.P. |
2.000 % w/w |
||
TRETINOIN |
U.S.P. |
0.025 % w/w |
||
MOMETASONE FUROATE |
I.P. |
0.100 % w/w |
||
CREAM BASE |
q.s. |
|||
108 |
DICLOFENAC DIETHYLAMINE, OLEUM LINI,METHYL SALICYLATE & MENTHOL GEL |
COMPOSITION: |
||
DICLOFENAC DIETHYLAMINE |
B.P. |
1.16 % w/w |
||
EQ. TO DICLOFENAC SODIUM |
1.00 % w/w |
|||
OLEUM LINI |
3.00 % w/w |
|||
(CONT. PREDOMINANTLY a-LINOLENIC ACID) |
||||
METHYL SALICYLATE |
I.P. |
10.00 % w/w |
||
MENTHOL |
I.P. |
5.00 % w/w |
||
BENZYL ALCOHOL (AS PRESERVATIVE) |
I.P. |
1.00 % w/w |
||
GEL BASE |
q.s. |
|||
109 |
DICLOFENAC DIETHYLAMINE, LINSEED OIL, METHYL SALICYLATE, CAPSAICIN & MENTHOL GEL |
COMPOSITION: |
||
DICLOFENAC DIETHYLAMINE |
B.P. |
1.16 % w/w |
||
EQ. TO DICLOFENAC SODIUM |
1.00 % w/w |
|||
LINSEED OIL |
B.P. |
3.00 % w/w |
||
METHYL SALICYLATE |
I.P. |
10.00 % w/w |
||
CAPSAICIN |
0.025 % w/w |
|||
MENTHOL |
I.P. |
5.00 % w/w |
||
GEL BASE |
q.s. |
|||
110 |
THYMOL,MENTHOL, ICHTHAMMOL & LIGNOCAINE OINTMENT |
COMPOSITION: |
||
THYMOL |
I.P. |
0.50 % w/w |
||
ICHTHAMMOL |
I.P. |
0.20 % w/w |
||
MENTHOL |
I.P. |
1.00 % w/w |
||
LIGNOCAINE |
I.P. |
1.00 % w/w |
||
OINTMENT BASE |
q.s. |
|||
111 |
CHLORBUTOL, BENZOCAINE & PARADICHLOROBENZENE EAR DROPS |
COMPOSITION: |
||
CHLORBUTOL |
I.P. |
5.00 % w/v |
||
BENZOCAINE |
I.P. |
2.50 % w/v |
||
PARADICHLOROBENZENE |
I.P. |
2.00 % w/v |
||
NON AQUEOUS BASE |
q.s. |
|||
112 |
SUCRALFATE & POVIDONE IODINE OINTMENT |
COMPOSITION: |
||
SUCRALFATE |
U.S.P. |
7.00 % w/w |
||
POVIDONE IODINE |
I.P. |
5.00 % w/w |
||
(AVAILABLE IODINE 0.50 % w/w) |
||||
WATER SOLUBLE OINTMENT BASE |
q.s. |
|||
WATER SOLUBLE MICROBIAL OINTMENT |
||||
113 |
CLINDAMYCIN PHOSPHATE & NICOTINAMIDE GEL |
COMPOSITION: |
||
CLINDAMYCIN PHOSPHATE |
I.P. |
|||
EQ. TO CLINDAMYCIN |
1 % w/w |
|||
NICOTINAMIDE |
I.P. |
4 % w/w |
||
IN ALOE, ALLANTION BASE WITH ETHYL LACTATE |
q.s. |
|||
114 |
TERBINAFINE HYDROCHLORIDE CREAM |
COMPOSITION : |
||
TERBINAFINE HYDROCHLORIDE |
B.P. |
1.00 % w/w |
||
BENZYL ALCOHOL (AS PRESERVATIVE) |
B.P. |
1.00 % w/w |
||
CREAM BASE |
q.s. |
|||
115 |
PERMETHRIN CREAM |
EACH GRAM OF CREAM CONTAINS : |
||
PERMETHRIN |
50 mg |
|||
CREAM BASE |
q.s. |
|||
116 |
PERMETHRIN LOTION |
COMPOSITION: |
||
PERMETHRIN |
5 % w/v |
|||
LOTION BASE |
q.s. |
|||
COLOUR : SUNSET YELLOW FCF |
||||
117 |
LULICONAZOLE CREAM |
COMPOSITION: |
||
LULICONAZOLE |
1.0 % w/w |
|||
PRESERVATIVE |
||||
BENZYL ALCOHOL |
I.P. |
1.0 % w/w |
||
CREAM BASE |
q.s. |
|||
118 |
GAMA BENZENE HEXACHLORIDE & CETRIMIDE LOTION |
COMPOSITION: |
||
GAMA BENZENE HEXACHLORIDE |
I.P. |
1.0 % w/v |
||
CETRIMIDE |
I.P. |
0.1 % w/v |
||
IN AN EMULSION BASE |
q.s. |
Sr. No. |
GENERIC NAME |
COMPOSITION |
||
69 |
IRON WITH VITAMIN B12 & B- COMPLEX SYRUP |
EACH 5ML. CONTAINS : |
||
FERRIC AMMONIUM CITRATE |
I.P |
150 mg |
||
(EQ. TO ELEMENTAL IRON 30 mg) |
||||
CYANOCOBALAMIN |
I.P. |
5.00 mcg |
||
FOLIC ACID |
I.P. |
1.0 mg |
||
ZINC SULPHATE MONOHYDRATE |
I.P. |
|||
EQ TO ELEMENTAL ZINC |
2.75 mg |
|||
FLAVOURED SYRUPY BASE |
q.s. |
|||
COLOUR : CARAMEL I.P. & ERYTHROSINE |
||||
70 |
IRON (III) HYDROXIDE POLYMALTOSE COMPLEX SYRUP |
EACH 5 ML CONTAINS : |
||
IRON(III) HYDROXIDE POLYMALTOSE |
||||
EQ. TO ELEMENTAL IRON |
50 mg |
|||
FLAVOURED SYRUP BASE |
q.s. |
|||
71 |
AZITHROMYCIN ORAL SUSPEN I.P. |
EACH 5 ML CONTAINS: |
||
AZITHROMYCIN DIHYDRATE |
I.P. |
|||
EQ. TO ANHYDROUS AZITHROMYCIN |
200 mg |
|||
FLAVOURED SYRUPY BASE |
q.s. |
|||
COLOUR: QUINOLINE YELLOW |
||||
72 |
FERROUS ASCORBATE & FOLIC ACID SUSPENSION |
EACH 5 ML CONTAINS : |
||
FERROUS ASCORBATE |
||||
EQ. TO ELEMENTAL IRON |
30 mg |
|||
FOLIC ACID |
I.P. |
550 mcg |
||
FLAVORED SYRUPY BASE |
q.s. |
|||
COLOUR : CARAMEL |
||||
73 |
PARACETAMOL, PHENYLEPHRINE HYDROCHLORIDE & CHLORPHENIRAMINE MALEATE SUSPENSION |
EACH ML CONTAINS : |
||
PARACETAMOL |
I.P. |
125 mg |
||
PHENYLEPHRINE HYDROCHLORIDE |
I.P. |
2.5 mg |
||
CHLORPHENIRAMINE MALEATE |
I.P. |
1 mg |
||
EXCIPIENTS |
q.s. |
|||
COLOUR:PONCEAU 4R |
||||
74 |
TERBUTALINE, BROMHEXINE HYDROCHLORIDE, GUAIPHENESIN & MENTHOL SYRUP |
EACH 5ML CONTAINS: |
||
TERBUTALINE SULPHATE |
I.P. |
1.25 mg |
||
BROMHEXINE HYDROCHLORIDE |
I.P. |
2 mg |
||
GUAIPHENESIN |
I.P. |
50 mg |
||
MENTHOL |
I.P. |
0.5 mg |
||
FALVOURED SYRUP BASE |
q.s. |
|||
COLOUR : SUNSET YELLOW FCF & |
||||
75 |
DIPHENHYDRAMINE HYDROCHLORIDE, AMMONIUM CHLORIDE, SODIUM CITRATE & MENTHOL SYRUP |
EACH 5ML CONTAINS: |
||
DIPHENHYDRAMINE HYDROCHLORIDE |
I.P. |
14.08 mg |
||
AMMONIUM CHLORIDE |
I.P. |
138 mg |
||
SODIUM CITRATE |
I.P. |
100 mg |
||
MENTHOL |
I.P. |
1.14 mg |
||
FLAVOURED SYRUP BASE |
q.s. |
|||
COLOUR: CARAMEL |
||||
76 |
SILYMARIN SUSPENSION |
EACH 5ML CONTAINS: |
||
SILYMARIN (AS SILYBIN) |
35 mg |
|||
FLAVOURED SYRUP BASE |
q.s. |
|||
COLOUR: SUNSET YELLOW FCF |
||||
77 |
CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE SYRUP |
EACH 5 ML CONTAINS: |
||
CHLORPHENIRAMINE MALEATE |
I.P. |
2 mg |
||
DEXTROMETHORPHAN HYDROBROMIDE |
I.P. |
10 mg |
||
PHENYLEPHRINE HYDROCHLORIDE |
I.P. |
5 mg |
||
IN FLAVOURED SYRUP BASE |
q.s. |
|||
COLOUR: BRILLIANT BLUE FCF & TARTRAZINE |
||||
78 |
AMBROXOL HYDROCLORIDE, GUAIPHENESIN & PHENYLEPHRINE HYDROCLORIDE SYRUP |
EACH 5 ML CONTAINS: |
||
AMBROXOL HYDROCLORIDE |
I.P. |
15 mg |
||
GUAIPHENESIN |
I.P. |
50 mg |
||
PHENYLEPHRINE HYDROCLORIDE |
I.P. |
2.5 mg |
||
IN A FLAVOURED SYP BASE |
q.s. |
|||
COLOUR: SUNSET YELLOW FCF |
||||
79 |
LEVOSALBUTAMOL SULPHATE, AMBROXOL HYDROCHLORIDE & GUAIPHENESIN SYRUP |
EACH 5ML CONTAINS : |
||
LEVOSALBUTAMOL SULPHATE |
I.P |
0.5 mg |
||
AMBROXOL HYDROCHLORIDE |
I.P. |
15 mg |
||
GUAIPHENESIN |
I.P. |
50 mg |
||
FLAVOURED SYRUP BASE |
q.s. |
|||
COLOUR : PONCEAU 4R |
||||
80 |
DISODIUM HYDROGEN CITRATE SYRUP |
EACH 5 ML CONTAINS: |
||
DISODIUM HYDROGEN CITRATE |
B.P. |
1.53 gm |
||
FLAVOURED SYRUP BASE |
q.s. |
|||
COLOUR: TARTRAZINE & ERYTHROSINE |
||||
81 |
MEFENAMIC ACID & PARACETAMOL ORAL SUSPENSION |
EACH 5 ML CONTAINS : |
||
MEFENAMIC ACID |
I.P. |
50 mg |
||
PARACETAMOL |
I.P. |
125 mg |
||
FLAVOURED SYRUPY BASE |
q.s. |
|||
COLOUR : SUNSET YELLOW FCF |